erycare va nov 2018
TRANSCRIPT
Erycare TabletsErythromycin 250 mg tablets
Quick target pain relief.Fast resolution of inflammation.
Normalizes fever promptly.
TARGET Antibiotic
for
TARGET Infections
Indicated for the treatment of the following infections caused by
susceptible strains of the designated microorganisms:
Mild to moderate severity caused by Streptococcus pyogenes (group A beta-hemolytic
streptococci); Streptococcus pneumoniae (Diplococcus pneumoniae); and Hemophilus
influenzae.
Mild to moderate severity when caused by Streptococcus pyogenes (group A beta-
hemolytic streptococci); Streptococcus pneumoniae ( Diplococcus pneumoniae); and
Mycoplasma pneumoniae (Eaton's agent).
caused by Bordetella pertussis.
caused by Legionella pneumophila.
Mild to moderate severity when caused by Streptococcus pyogenes and Staphylococcus
aureus (resistance of staphylococci may emerge during treatment).
in the treatment of infections due to Corynebacterium minutissimum.
caused by Treponema pallidum. Erythromycin is an alternate choice
for treatment for primary syphilis in patients allergic to the penicillins.
Erythromycin is an alternate choice in the treatment
of the infections caused by Chlamydia trachomatis.
Specimens for bacteriologic culture should be obtained prior to therapy in order to
isolate and identify the causative organisms and to determine their susceptibility to
erythromycin.
Upper Respiratory Tract Infections:
Lower Respiratory Tract Infections:
Pertussis (Whooping Cough) Prophylaxis:
Legionnaires' Disease:
Skin and Soft Tissue Infections:
Erythrasma:
The treatment of Acne vulgaris
Sexually Transmitted Diseases: Primary Syphilis:
Chlamydia Trachomatis Infection:Erycare TabletsErythromycin 250 mg tablets